Novel ML Blood Test Detects Cancers with Genome-Wide Mutations in cfDNA Molecules
New blood testing tech combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning.
Read MorePosted by Andy Lundin | Jul 27, 2023 | Cancer |
New blood testing tech combines genome-wide sequencing of single molecules of DNA shed from tumors and machine learning.
Read MorePosted by Andy Lundin | Jul 25, 2023 | Cancer |
GBC’s two CTC detection systems are used for early detection, treatment validation, and therapy monitoring with rapid diagnostic solutions.
Read MorePosted by Andy Lundin | Jul 17, 2023 | Miscellaneous |
An estimated 795,000 Americans die or are permanently disabled by diagnostic error each year, according to a new analysis of national data.
Read MorePosted by Chris Wolski | Jul 12, 2023 | Molecular Diagnostic Analyzers |
CareDx, Inc. has announced that its AlloSure Lung donor-derived cell-free DNA molecular testing service has received Medicare coverage.
Read MorePosted by Chris Wolski | Jun 30, 2023 | Lung Cancer |
A blood-based test developed by researchers can predict the risk of dying from lung cancer when combined with a personalized risk model.
Read More